Emerging new predictive biomarkers in metastatic breast cancer: Caveolin-1 and weekly nab-paclitaxel plus gemcitabine, are we on for tomorrow?1 Oct 2019Chinese Clinical Oncology DOI : 10.21037/cco.2019.01.08AuthorsFrancesco Ricci, Christophe Le Tourneau